2023 Q3 Form 10-K Financial Statement

#000173112224000378 Filed on March 08, 2024

View on sec.gov

Income Statement

Concept 2023 Q3 2023 2022 Q3
Revenue $114.2K $307.3K $26.78K
YoY Change 326.44% 453.57% -89.92%
Cost Of Revenue $88.10K $238.8K $17.11K
YoY Change 414.9% 513.81% -74.35%
Gross Profit $26.10K $68.52K $9.670K
YoY Change 169.91% 312.5% -95.14%
Gross Profit Margin 22.85% 22.3% 36.11%
Selling, General & Admin $238.8K $774.5K $234.9K
YoY Change 1.66% 617.51% -241.18%
% of Gross Profit 914.98% 1130.25% 2429.37%
Research & Development $13.94K $56.53K $15.72K
YoY Change -11.32% -8.14%
% of Gross Profit 53.41% 82.5% 162.56%
Depreciation & Amortization $9.470K $36.78K $8.440K
YoY Change 12.2% 335.99% -70.57%
% of Gross Profit 36.28% 53.68% 87.28%
Operating Expenses $252.7K $831.0K $250.6K
YoY Change 0.85% -30.85% 64.58%
Operating Profit -$226.6K -$762.5K -$241.0K
YoY Change -5.94% -35.67% -617.53%
Interest Expense $80.03K -$9.090K $401.8K
YoY Change -80.08% -112.92%
% of Operating Profit
Other Income/Expense, Net -$49.73K -$122.3K $98.95K
YoY Change -150.26% -57.86% -3477.13%
Pretax Income -$232.7K -$930.1K $259.8K
YoY Change -189.55% -36.96% 495.46%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$232.7K -$930.1K $259.8K
YoY Change -189.55% -36.96% 495.46%
Net Earnings / Revenue -203.73% -302.7% 970.13%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share $0.00 -$0.01 $0.00
COMMON SHARES
Basic Shares Outstanding 106.5M shares 105.3M shares
Diluted Shares Outstanding 106.5M shares

Balance Sheet

Concept 2023 Q3 2023 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.630K $4.630K $127.1K
YoY Change -96.36% -96.36% -63.67%
Cash & Equivalents $4.632K $127.1K
Short-Term Investments
Other Short-Term Assets $18.56K $18.56K $10.50K
YoY Change 76.76% 76.76% -94.52%
Inventory
Prepaid Expenses $10.50K
Receivables $11.58K $11.58K $6.082K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $34.78K $34.78K $143.7K
YoY Change -75.79% -75.8% 360.11%
LONG-TERM ASSETS
Property, Plant & Equipment $184.2K $184.2K $149.4K
YoY Change 23.29% 23.29% 478.51%
Goodwill
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $196.0K $196.0K $149.4K
YoY Change 31.17% 31.17%
TOTAL ASSETS
Total Short-Term Assets $34.78K $34.78K $143.7K
Total Long-Term Assets $196.0K $196.0K $149.4K
Total Assets $230.8K $230.8K $293.1K
YoY Change -21.26% -21.26% 838.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $664.7K $664.7K $198.1K
YoY Change 235.59% 235.59% 17.31%
Accrued Expenses $4.920K $4.920K $29.04K
YoY Change -83.06% -83.06% 157.92%
Deferred Revenue
YoY Change
Short-Term Debt $62.50K $62.50K $0.00
YoY Change -100.0%
Long-Term Debt Due $1.110M $1.110M $755.8K
YoY Change 46.87% 46.87%
Total Short-Term Liabilities $1.878M $1.878M $1.100M
YoY Change 70.71% 70.71% 379.93%
LONG-TERM LIABILITIES
Long-Term Debt $307.1K $307.1K $292.2K
YoY Change 5.09% 5.09%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $307.1K $307.1K $292.2K
YoY Change 5.09% 5.09% -77.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.878M $1.878M $1.100M
Total Long-Term Liabilities $307.1K $307.1K $292.2K
Total Liabilities $2.185M $2.185M $1.392M
YoY Change 56.94% 56.94% 169.52%
SHAREHOLDERS EQUITY
Retained Earnings -$3.311M -$2.381M
YoY Change 39.07% 162.95%
Common Stock $1.375M $1.300M
YoY Change 5.77% 209.6%
Preferred Stock
YoY Change
Treasury Stock (at cost) $18.13K $18.13K
YoY Change 0.0%
Treasury Stock Shares 15.10K shares
Shareholders Equity -$1.954M -$1.954M -$1.099M
YoY Change
Total Liabilities & Shareholders Equity $230.8K $230.8K $293.1K
YoY Change -21.26% -21.26% 838.61%

Cashflow Statement

Concept 2023 Q3 2023 2022 Q3
OPERATING ACTIVITIES
Net Income -$232.7K -$930.1K $259.8K
YoY Change -189.55% -36.96% 495.46%
Depreciation, Depletion And Amortization $9.470K $36.78K $8.440K
YoY Change 12.2% 335.99% -70.57%
Cash From Operating Activities -$78.75K -$445.1K -$827.6K
YoY Change -90.48% -46.22% 4797.1%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $72.87K $157.9K
YoY Change -100.0% -53.84% -969.27%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $70.36K
YoY Change -100.0% -100.0% 8377.11%
Cash From Investing Activities $0.00 -$72.87K -$87.50K
YoY Change -100.0% -16.72% 404.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 71.16K 414.1K 1.032M
YoY Change -93.11% -59.9%
NET CHANGE
Cash From Operating Activities -78.75K -445.1K -827.6K
Cash From Investing Activities 0.000 -72.87K -87.50K
Cash From Financing Activities 71.16K 414.1K 1.032M
Net Change In Cash -7.590K -103.9K 117.3K
YoY Change -106.47% -188.57% -442.8%
FREE CASH FLOW
Cash From Operating Activities -$78.75K -$445.1K -$827.6K
Capital Expenditures $0.00 $72.87K $157.9K
Free Cash Flow -$78.75K -$518.0K -$985.5K
YoY Change -92.01% -47.44% -78311.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001394638
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
usd
CY2022Q3 clcn Accrued Interestrelated Parties
AccruedInterestrelatedParties
usd
CY2022Q3 us-gaap Customer Deposits Current
CustomerDepositsCurrent
usd
CY2022Q3 clcn Promissory Notes Payable Net Of Debt Discount
PromissoryNotesPayableNetOfDebtDiscount
usd
CY2022Q3 clcn Promissory Notes Payable In Default
PromissoryNotesPayableInDefault
usd
CY2022Q3 clcn Promissory Notes Payable Related Parties In Default
PromissoryNotesPayableRelatedPartiesInDefault
usd
CY2022Q3 clcn Promissory Notes Payable Noncurrent
PromissoryNotesPayableNoncurrent
usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023 clcn Gain On Ppp Loan Forgiveness
GainOnPppLoanForgiveness
usd
CY2022 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
usd
CY2023 us-gaap Interest Income Other
InterestIncomeOther
usd
CY2023 us-gaap Other Income
OtherIncome
usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2022 clcn Conversion Of Preferred Stock To Common Stock
ConversionOfPreferredStockToCommonStock
usd
CY2023 clcn Gain On Ppp Loan Forgiveness
GainOnPppLoanForgiveness
usd
CY2022 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
usd
CY2023 clcn Increase Decrease In Prepaid Website Development
IncreaseDecreaseInPrepaidWebsiteDevelopment
usd
CY2022 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
usd
CY2023 clcn Acquisition Of Subsidiary
AcquisitionOfSubsidiary
usd
CY2022 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2022 clcn Proceeds From Promissory Notes Payable Related Parties
ProceedsFromPromissoryNotesPayableRelatedParties
usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023 clcn Preferred Stock Issued For Conversions Of Debt Related Party
PreferredStockIssuedForConversionsOfDebtRelatedParty
usd
CY2023 clcn Preferred Stock Issued For Conversion Of Debt
PreferredStockIssuedForConversionOfDebt
usd
CY2023 clcn Common Stock And Warrant Issued In Connections With Promissory Note
CommonStockAndWarrantIssuedInConnectionsWithPromissoryNote
usd
CY2022 clcn Common Stock In Connection With Promissory Note
CommonStockInConnectionWithPromissoryNote
usd
CY2023 clcn Preferred Stock Issued For Exercise Of Stock Option Related Party
PreferredStockIssuedForExerciseOfStockOptionRelatedParty
usd
CY2023 clcn Conversion Of Preferred Stock To Common Stocks
ConversionOfPreferredStockToCommonStocks
usd
CY2023 clcn Cancellation Of Common Share Against Note Receivable
CancellationOfCommonShareAgainstNoteReceivable
usd
CY2022 clcn Prepaid Expenses Reclassified To Intangible Assets
PrepaidExpensesReclassifiedToIntangibleAssets
usd
CY2023 clcn Note Receivable Exchanged For Settlement Of Accrued Wages
NoteReceivableExchangedForSettlementOfAccruedWages
usd
CY2023Q3 us-gaap Fair Value Hedge Liabilities At Fair Value
FairValueHedgeLiabilitiesAtFairValue
usd
CY2022Q3 us-gaap Fair Value Hedge Liabilities At Fair Value
FairValueHedgeLiabilitiesAtFairValue
usd
CY2021Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
usd
CY2022Q3 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
usd
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-52883
CY2023 dei Entity Registrant Name
EntityRegistrantName
DRIVEITAWAY HOLDINGS, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4456503
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
3201 Market Street
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200/201
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Philadelphia
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10104
CY2023 dei City Area Code
CityAreaCode
(856)
CY2023 dei Local Phone Number
LocalPhoneNumber
577-2763
CY2023 dei Security12g Title
Security12gTitle
Common Stock, par value $0.0001 per share
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Public Float
EntityPublicFloat
706337 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
106551722 shares
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Auditor Firm
AuditorFirmId
6258
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10498 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
34775 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
143689 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
184228 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
149428 usd
CY2023 dei Auditor Name
AuditorName
Mac Accounting Group & CPAs, LLP
CY2023 dei Auditor Location
AuditorLocation
Midvale, Utah
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4632 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
127109 usd
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
18559 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11584 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6082 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2380759 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1954359 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-1099222 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11787 usd
CY2023Q3 us-gaap Assets
Assets
230790 usd
CY2022Q3 us-gaap Assets
Assets
293117 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
664707 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
227109 usd
CY2023Q3 clcn Accrued Interestrelated Parties
AccruedInterestrelatedParties
4918 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
7233 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2101 usd
CY2023Q3 us-gaap Customer Deposits Current
CustomerDepositsCurrent
2234 usd
CY2023Q3 clcn Due To Related Party Current
DueToRelatedPartyCurrent
25080 usd
CY2022Q3 clcn Due To Related Party Current
DueToRelatedPartyCurrent
80 usd
CY2023Q3 clcn Promissory Notes Payable Net Of Debt Discount
PromissoryNotesPayableNetOfDebtDiscount
27437 usd
CY2023Q3 clcn Promissory Notes Payable In Default
PromissoryNotesPayableInDefault
12500 usd
CY2023Q3 clcn Promissory Notes Payable Related Parties In Default
PromissoryNotesPayableRelatedPartiesInDefault
50000 usd
CY2023Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1082654 usd
CY2022Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
750000 usd
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1317 usd
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
115009 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1878080 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1094299 usd
CY2023Q3 clcn Sba Loan Noncurrent
SbaLoanNoncurrent
114700 usd
CY2022Q3 clcn Sba Loan Noncurrent
SbaLoanNoncurrent
114700 usd
CY2023Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
175720 usd
CY2022Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
183340 usd
CY2023Q3 clcn Promissory Notes Payable Noncurrent
PromissoryNotesPayableNoncurrent
16649 usd
CY2023Q3 us-gaap Liabilities
Liabilities
2185149 usd
CY2022Q3 us-gaap Liabilities
Liabilities
1392339 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
106551722 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
106536622 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
105301722 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
105286622 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
10656 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
10531 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1364007 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1289132 usd
CY2023Q3 clcn Treasury Stock Share
TreasuryStockShare
15100 shares
CY2022Q3 clcn Treasury Stock Share
TreasuryStockShare
15100 shares
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
18126 usd
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
18126 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3310896 usd
CY2022 clcn Common Stock And Warrant Issued In Connection With Promissory Note
CommonStockAndWarrantIssuedInConnectionWithPromissoryNote
65274 usd
CY2022 clcn Cancellation Of Common Shares Against Note Receivable
CancellationOfCommonSharesAgainstNoteReceivable
-100000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1475365 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-1099222 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
230790 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
293117 usd
CY2023 us-gaap Revenues
Revenues
307284 usd
CY2022 us-gaap Revenues
Revenues
55509 usd
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
238763 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
38898 usd
CY2023 us-gaap Gross Profit
GrossProfit
68521 usd
CY2022 us-gaap Gross Profit
GrossProfit
16611 usd
CY2023 us-gaap Salaries And Wages
SalariesAndWages
297625 usd
CY2022 us-gaap Salaries And Wages
SalariesAndWages
388100 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
345101 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
644189 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
92749 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
74053 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
56529 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
61542 usd
CY2023 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
38972 usd
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
33883 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
830976 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
1201767 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-762455 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1185156 usd
CY2023 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
169723 usd
CY2022 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
435188 usd
CY2022 clcn Gain On Ppp Loan Forgiveness
GainOnPppLoanForgiveness
-24148 usd
CY2023 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
36313 usd
CY2023 clcn Amortization Of Debt Discount
AmortizationOfDebtDiscount
122279 usd
CY2022 clcn Amortization Of Debt Discount
AmortizationOfDebtDiscount
677561 usd
CY2023 us-gaap Interest Expense
InterestExpense
173895 usd
CY2022 us-gaap Interest Expense
InterestExpense
70346 usd
CY2023 clcn Interest Expense Related Parties
InterestExpenseRelatedParties
4918 usd
CY2022 clcn Interest Expense Related Parties
InterestExpenseRelatedParties
2296 usd
CY2022 us-gaap Interest Income Other
InterestIncomeOther
12 usd
CY2022 us-gaap Other Income
OtherIncome
646 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-167682 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-290209 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-930137 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1475365 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-930137 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1475365 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106458571 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
106458571 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50013328 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50013328 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-485371 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
288461 usd
CY2022 clcn Preferred Stock Issued For Conversion Of Debt Related Party
PreferredStockIssuedForConversionOfDebtRelatedParty
104565 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
288459 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
84374 usd
CY2022 clcn Recapitalization
Recapitalization
130381 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-1099222 usd
CY2023 clcn Common Stock Issued In Connection With Promissory Note
CommonStockIssuedInConnectionWithPromissoryNote
60000 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
15000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-930137 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1954359 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-930137 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1475365 usd
CY2022 clcn Gain On Ppp Loan Forgiveness
GainOnPppLoanForgiveness
-24148 usd
CY2023 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
36313 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
15000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
288461 usd
CY2023 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
169723 usd
CY2022 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
435188 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
36783 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
8436 usd
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
122279 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
677561 usd
CY2022 clcn Increase Decrease In Prepaid Website Development
IncreaseDecreaseInPrepaidWebsiteDevelopment
10498 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5502 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-15373 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5132 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2101 usd
CY2023 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
2234 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
437598 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
123279 usd
CY2023 clcn Increase Decrease In Accrued Interest Related Party
IncreaseDecreaseInAccruedInterestRelatedParty
4918 usd
CY2022 clcn Increase Decrease In Accrued Interest Related Party
IncreaseDecreaseInAccruedInterestRelatedParty
2377 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-445105 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-827611 usd
CY2022 clcn Acquisition Of Subsidiary
AcquisitionOfSubsidiary
-70360 usd
CY2023 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
5833 usd
CY2023 clcn Payments To Acquire Property Plant And Equipments
PaymentsToAcquirePropertyPlantAndEquipments
67039 usd
CY2022 clcn Payments To Acquire Property Plant And Equipments
PaymentsToAcquirePropertyPlantAndEquipments
157864 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-72872 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-87504 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
26460 usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1460 usd
CY2023 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
310000 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1125000 usd
CY2023 clcn Proceeds From Promissory Notes Payable Related Parties
ProceedsFromPromissoryNotesPayableRelatedParties
50000 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
104458 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
36200 usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
42011 usd
CY2023 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
33388 usd
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
128750 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
414059 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1032450 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-103918 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
117335 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127109 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9774 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23191 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127109 usd
CY2023 us-gaap Increase Decrease In Prepaid Interest
IncreaseDecreaseInPrepaidInterest
49863 usd
CY2022 us-gaap Increase Decrease In Prepaid Interest
IncreaseDecreaseInPrepaidInterest
45203 usd
CY2022 clcn Preferred Stock Issued For Conversions Of Debt Related Party
PreferredStockIssuedForConversionsOfDebtRelatedParty
104564 usd
CY2022 clcn Preferred Stock Issued For Conversion Of Debt
PreferredStockIssuedForConversionOfDebt
288458 usd
CY2022 clcn Common Stock And Warrant Issued In Connections With Promissory Note
CommonStockAndWarrantIssuedInConnectionsWithPromissoryNote
65274 usd
CY2023 clcn Common Stock In Connection With Promissory Note
CommonStockInConnectionWithPromissoryNote
60000 usd
CY2022 clcn Preferred Stock Issued For Exercise Of Stock Option Related Party
PreferredStockIssuedForExerciseOfStockOptionRelatedParty
84375 usd
CY2022 clcn Conversion Of Preferred Stock To Common Stocks
ConversionOfPreferredStockToCommonStocks
8809 usd
CY2022 clcn Cancellation Of Common Share Against Note Receivable
CancellationOfCommonShareAgainstNoteReceivable
100000 usd
CY2023 clcn Recognition Of Derivative Liability As Debt Discount
RecognitionOfDerivativeLiabilityAsDebtDiscount
26959 usd
CY2022 clcn Recognition Of Derivative Liability As Debt Discount
RecognitionOfDerivativeLiabilityAsDebtDiscount
550197 usd
CY2023 clcn Prepaid Expenses Reclassified To Intangible Assets
PrepaidExpensesReclassifiedToIntangibleAssets
10498 usd
CY2022 clcn Note Receivable Exchanged For Settlement Of Accrued Wages
NoteReceivableExchangedForSettlementOfAccruedWages
50000 usd
CY2023 clcn Number Of Shares Exchaged
NumberOfSharesExchaged
2594593 shares
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-930137 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-445105 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3310896 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_zpLn388TvJuc" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5pt"><span id="xdx_86E_zr4Ilkb4sPj9">Use of Estimates</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The significant estimates and assumptions made by management include allowance for doubtful accounts, allowance for deferred tax assets, and fair value of equity instruments. Actual results could differ from those estimates as the current economic environment has increased the degree of uncertainty inherent in these estimates and assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt"> </p>
CY2023Q3 us-gaap Cash
Cash
4632 usd
CY2022Q3 us-gaap Cash
Cash
127109 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
18559 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
18559 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q3 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P3Y
CY2023Q3 clcn Derivative Liability
DerivativeLiability
1317 usd
CY2022Q3 clcn Derivative Liability
DerivativeLiability
115009 usd
CY2023 us-gaap Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
<p id="xdx_842_eus-gaap--DerivativesReportingOfDerivativeActivity_zWcFj4UA8G9d" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5pt"><span id="xdx_866_z52lUtgZRoY4">Derivative Financial Instruments</span></p> <p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">The Company accounts for their derivative financial instruments in accordance with ASC 815 “Derivatives and Hedging” therefore any embedded conversion options and warrants accounted for as derivatives are to be recorded at their fair values as of the inception date of the agreement and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded as non-operating, non-cash income or expense for each reporting period at each balance sheet date. The Company reassesses the classification of its derivative instruments at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">The Black-Scholes option valuation model was used to estimate the fair value of the embedded conversion options and warrants. The model includes subjective input assumptions that can materially affect the fair value estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt"> </p>
CY2023Q3 clcn Refundable Deposits
RefundableDeposits
2234 usd
CY2022Q3 clcn Refundable Deposits
RefundableDeposits
0 usd
CY2023Q3 clcn Deferred Revenues
DeferredRevenues
7233 usd
CY2022Q3 clcn Deferred Revenues
DeferredRevenues
2101 usd
CY2023 us-gaap Advertising Expense
AdvertisingExpense
38972 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
33883 usd
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4100000 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
60514535 shares
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_847_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zV7DOtFQzy35" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><span id="xdx_86E_zM0p1qAJNO02"><b><i>Reclassification</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in">Certain accounts from prior periods have been reclassified to conform to the current period presentation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0in"> </p>
CY2019Q3 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.06 pure
CY2019Q3 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
1000000 usd
CY2023 clcn Interest Expense Related Parties
InterestExpenseRelatedParties
4918 usd
CY2022 clcn Interest Expense Related Parties
InterestExpenseRelatedParties
2296 usd
CY2023Q3 clcn Convertible Note Payable Related Party
ConvertibleNotePayableRelatedParty
0 usd
CY2023Q3 clcn Debt Instrument Outstanding Principal
DebtInstrumentOutstandingPrincipal
50000 usd
CY2023 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
4918 usd
CY2023Q3 clcn Due To Related Party Current
DueToRelatedPartyCurrent
25080 usd
CY2022Q3 clcn Due To Related Party Current
DueToRelatedPartyCurrent
80 usd
CY2023Q3 us-gaap Notes Receivable Net
NotesReceivableNet
150000 usd
CY2023 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2022-04-20
CY2023 us-gaap Debt Instrument Interest Rate Increase Decrease
DebtInstrumentInterestRateIncreaseDecrease
0.15 pure
CY2023 clcn Note Issued For Cancellation Of Common Stock
NoteIssuedForCancellationOfCommonStock
500000 shares
CY2022Q2 clcn Note Issued For Cancellation Of Common Stock
NoteIssuedForCancellationOfCommonStock
500000 shares
CY2023 us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
50000 usd
CY2022Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
0 usd
CY2023Q3 us-gaap Capitalized Costs Support Equipment And Facilities
CapitalizedCostsSupportEquipmentAndFacilities
224903 usd
CY2022Q3 us-gaap Capitalized Costs Support Equipment And Facilities
CapitalizedCostsSupportEquipmentAndFacilities
157864 usd
CY2023Q3 clcn Accumulated Depreciation Of Vehicles
AccumulatedDepreciationOfVehicles
40675 usd
CY2022Q3 clcn Accumulated Depreciation Of Vehicles
AccumulatedDepreciationOfVehicles
8436 usd
CY2023Q3 us-gaap Public Utilities Property Plant And Equipment Vehicles
PublicUtilitiesPropertyPlantAndEquipmentVehicles
184228 usd
CY2022Q3 us-gaap Public Utilities Property Plant And Equipment Vehicles
PublicUtilitiesPropertyPlantAndEquipmentVehicles
149428 usd
CY2023 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
67039 usd
CY2022 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
157864 usd
CY2023 us-gaap Depreciation
Depreciation
32239 usd
CY2022 us-gaap Depreciation
Depreciation
8436 usd
CY2023Q3 clcn Website Development Costs
WebsiteDevelopmentCosts
16331 usd
CY2022Q3 clcn Website Development Costs
WebsiteDevelopmentCosts
0 usd
CY2023Q3 clcn Accumulated Depreciation Of Website Development
AccumulatedDepreciationOfWebsiteDevelopment
4544 usd
CY2022Q3 clcn Accumulated Depreciation Of Website Development
AccumulatedDepreciationOfWebsiteDevelopment
-0 usd
CY2023Q3 clcn Website Net
WebsiteNet
11787 usd
CY2022Q3 clcn Website Net
WebsiteNet
0 usd
CY2022 clcn Website Development
WebsiteDevelopment
10498 usd
CY2023 clcn Website Development
WebsiteDevelopment
5833 usd
CY2023 clcn Prepaid Expenses Reclassified To Intangible Assets
PrepaidExpensesReclassifiedToIntangibleAssets
10498 usd
CY2023 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
4544 usd
CY2022 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
0 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023 us-gaap Preferred Stock Redemption Terms
PreferredStockRedemptionTerms
The Series A Preferred Stock is entitled to receive, prior to any distribution to any junior class of securities, an amount equal to $0.01 per share as a liquidation preference before any distribution may be made to the holders of any junior security, including the Common Stock
CY2023 us-gaap Preferred Stock Voting Rights
PreferredStockVotingRights
Each holder of Series A Preferred Stock shall vote with holders of the Common Stock upon any matter submitted to a vote of shareholders, in which event it shall have the number of votes equal to the number of shares of Common Stock into which such share of Series A Preferred Stock would be convertible on the record date for the vote or consent of shareholders. Each holder of Series A Preferred Stock shall also be entitled to one vote per share on each submitted to a class vote of the holders of Series A Preferred Stock.
CY2023 us-gaap Conversion Of Stock Description
ConversionOfStockDescription
Each share of Series A Preferred Stock is convertible into 33.94971 shares of Common Stock at the option of the holder thereof.
CY2023 clcn Mandatory Conversion Right Description
MandatoryConversionRightDescription
The Company has the right to convert each share of Series A Preferred Stock into 33.94971 shares of Common Stock at any time that there are less than 200,000 shares of Series A Preferred Stock outstanding.
CY2023 clcn Stockbased Compensation Expense
StockbasedCompensationExpense
0 usd
CY2022 clcn Stockbased Compensation Expense
StockbasedCompensationExpense
288461 usd
CY2022Q1 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
52284 shares
CY2022Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
104565 usd
CY2023 clcn Stock Issued During Period Share Conversion Of Convertible Securities
StockIssuedDuringPeriodShareConversionOfConvertibleSecurities
129809 shares
CY2023 clcn Stock Issued For Conversion Of Debt Value
StockIssuedForConversionOfDebtValue
288458 usd
CY2023 clcn Stock Issued During Period Share Stock Options Exercised
StockIssuedDuringPeriodShareStockOptionsExercised
112500 shares
CY2023 clcn Stock Issued During Period Value Stocks Options Exercised
StockIssuedDuringPeriodValueStocksOptionsExercised
84375 usd
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
70360 usd
CY2022Q1 clcn Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Note Receivable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoteReceivable
150000 usd
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
89979 usd
CY2023 clcn Derivative Guarantee
DerivativeGuarantee
384287 usd
CY2023 clcn Derivative Warrant
DerivativeWarrant
107283 usd
CY2023Q3 us-gaap Shares Issued
SharesIssued
4000000 shares
CY2023 clcn Commitment Fee
CommitmentFee
65274 usd
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
130381 usd
CY2022Q1 clcn Shares Issued For Commitment Fees
SharesIssuedForCommitmentFees
4000000 shares
CY2022Q1 clcn Shares Issued For Commitment Fees Value
SharesIssuedForCommitmentFeesValue
65274 usd
CY2022Q1 clcn Shares Issued For Promissory Note Value
SharesIssuedForPromissoryNoteValue
750000 usd
CY2022Q2 clcn Note Issued For Cancellation Of Common Stock
NoteIssuedForCancellationOfCommonStock
500000 shares
CY2022Q2 us-gaap Notes Receivable Net
NotesReceivableNet
100000 usd
CY2022Q4 clcn Shares Issued For Market Fair Value Shares
SharesIssuedForMarketFairValueShares
250000 shares
CY2022Q4 clcn Shares Issued For Market Fair Value
SharesIssuedForMarketFairValue
15000 usd
CY2022Q4 clcn Shares Issued For Commitment Fees
SharesIssuedForCommitmentFees
1000000 shares
CY2022Q4 clcn Shares Issued For Commitment Fees Value
SharesIssuedForCommitmentFeesValue
60000 usd
CY2022Q4 clcn Shares Issued For Promissory Note Value
SharesIssuedForPromissoryNoteValue
750000 usd
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
106551722 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
105301722 shares
CY2023Q3 clcn Treasury Stock Share
TreasuryStockShare
15100 shares
CY2022Q3 clcn Treasury Stock Share
TreasuryStockShare
15100 shares
CY2023Q3 clcn Treasury Stock Values
TreasuryStockValues
18126 usd
CY2022Q3 clcn Treasury Stock Values
TreasuryStockValues
18126 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
300000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.75
CY2022Q1 clcn Shares Issued For Promissory Note Value
SharesIssuedForPromissoryNoteValue
750000 usd
CY2022Q1 clcn Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issuance Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuanceNumber
1000000 shares
CY2022Q1 clcn Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issuance In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuanceInPeriodWeightedAverageGrantDateFairValue
0.30
CY2022Q1 clcn Derivative Liabilities Dept Discount
DerivativeLiabilitiesDeptDiscount
107283 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Expiration Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
2027-02-24
CY2022Q2 clcn Shares Issued For Promissory Note Value
SharesIssuedForPromissoryNoteValue
250000 usd
clcn Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issuance Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuanceNumber
125000 shares
clcn Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issuance In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuanceInPeriodWeightedAverageGrantDateFairValue
0.30
CY2022Q2 clcn Derivative Liabilities Dept Discount
DerivativeLiabilitiesDeptDiscount
8136 usd
CY2022Q4 clcn Shares Issued For Promissory Note Value
SharesIssuedForPromissoryNoteValue
200000 usd
CY2022Q4 clcn Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issuance Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuanceNumber
100000 shares
CY2022Q4 clcn Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issuance In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuanceInPeriodWeightedAverageGrantDateFairValue
0.30
CY2022Q4 clcn Derivative Liabilities Dept Discount
DerivativeLiabilitiesDeptDiscount
4074 usd
CY2023Q1 us-gaap Class Of Warrant Or Right Unissued
ClassOfWarrantOrRightUnissued
1000000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.05
CY2023Q3 us-gaap Convertible Debt
ConvertibleDebt
2000000 usd
CY2022Q1 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
72368 shares
CY2023 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
0 usd
CY2022 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
4833 usd
CY2023Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
384287 usd
CY2023 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
4000000 shares
CY2023 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
65274 usd
CY2023 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
108750 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
665594 usd
CY2022Q2 clcn Warrants Issued
WarrantsIssued
125000 shares
CY2022Q4 clcn Warrants Issued
WarrantsIssued
100000 shares
CY2022 us-gaap Interest Expense Other
InterestExpenseOther
11583 usd
CY2022Q3 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
11967 usd
CY2022Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
66660 usd
CY2022Q3 us-gaap Notes Payable
NotesPayable
183340 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
11583 usd
CY2023 us-gaap Interest Expense Other
InterestExpenseOther
64605 usd
CY2023 us-gaap Interest Paid
InterestPaid
13125 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
58158 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
51626 usd
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
450000 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
398374 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
63063 usd
CY2023 clcn Commitment Fee Guarantee Issued
CommitmentFeeGuaranteeIssued
294 usd
CY2023 clcn Fair Value Adjustments Of Warrants
FairValueAdjustmentsOfWarrants
369 usd
CY2023 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
44 usd
CY2023 clcn Fair Value Adjustment Of Warrant
FairValueAdjustmentOfWarrant
19 usd
CY2023 clcn Embedded Derivative Gain Loss On Embedded Derivatives Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativesNet
126 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
18 usd
CY2023 clcn Embedded Derivative Gain Loss On Embedded Derivatives
EmbeddedDerivativeGainLossOnEmbeddedDerivatives
110 usd
CY2023 clcn Fair Value Adjustment Of Warrants1
FairValueAdjustmentOfWarrants1
24 usd
CY2023 clcn Fair Value Adjustment Of Warrants2
FairValueAdjustmentOfWarrants2
274 usd
CY2023 clcn Fair Value Adjustment Of Warrants3
FairValueAdjustmentOfWarrants3
39 usd
CY2023 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
1317 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.000 pure
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
14900 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.010 pure
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
229800 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.247 pure
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
415700 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.282 pure
CY2022 clcn Addition Of New Derivatives Recognized As Debt Discounts
AdditionOfNewDerivativesRecognizedAsDebtDiscounts
550197 usd
CY2022 clcn Gain On Change In Fair Value Of Derivative
GainOnChangeInFairValueOfDerivative
-435188 usd
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
115009 usd
CY2023 clcn Addition Of New Derivatives Recognized As Debt Discounts
AdditionOfNewDerivativesRecognizedAsDebtDiscounts
26959 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
29072 usd
CY2023 clcn Gain On Change In Fair Value Of Derivative
GainOnChangeInFairValueOfDerivative
-169723 usd
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1317 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.31 pure
CY2023Q3 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
773800 usd
CY2022Q3 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
570300 usd
CY2023Q3 clcn Deferred Tax Assets In Process Accruals
DeferredTaxAssetsInProcessAccruals
17800 usd
CY2022Q3 clcn Deferred Tax Assets In Process Accruals
DeferredTaxAssetsInProcessAccruals
1200 usd
CY2023Q3 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
14700 usd
CY2023Q3 clcn Deferred Tax Assets Depreciation Amortization
DeferredTaxAssetsDepreciationAmortization
12200 usd
CY2022Q3 clcn Deferred Tax Assets Depreciation Amortization
DeferredTaxAssetsDepreciationAmortization
7200 usd
CY2023Q3 clcn Deferred Tax Assets Valuation Allowances
DeferredTaxAssetsValuationAllowances
794100 usd
CY2022Q3 clcn Deferred Tax Assets Valuation Allowances
DeferredTaxAssetsValuationAllowances
564300 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-195300 usd
CY2023 clcn Effective Income Tax Rate Reconciliation At Expected Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtExpectedFederalStatutoryIncomeTaxRate
0.210 pure
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-309800 usd
CY2022 clcn Effective Income Tax Rate Reconciliation At Expected Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtExpectedFederalStatutoryIncomeTaxRate
0.210 pure
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-73500 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.079 pure
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-227500 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.154 pure
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
800 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001 pure
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
106700 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.072 pure
CY2023 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
38200 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.041 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.000 pure
CY2022Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1700000 usd
CY2023Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2677000 usd

Files In Submission

Name View Source Status
0001731122-24-000378-index-headers.html Edgar Link pending
0001731122-24-000378-index.html Edgar Link pending
0001731122-24-000378.txt Edgar Link pending
0001731122-24-000378-xbrl.zip Edgar Link pending
clcn-20230930.xsd Edgar Link pending
e5448_10k.htm Edgar Link pending
e5448_ex21.htm Edgar Link pending
e5448_ex31-1.htm Edgar Link pending
e5448_ex31-2.htm Edgar Link pending
e5448_ex32-1.htm Edgar Link pending
e5448_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
clcn-20230930_def.xml Edgar Link unprocessable
clcn-20230930_lab.xml Edgar Link unprocessable
clcn-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
e5448_10k_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
clcn-20230930_cal.xml Edgar Link unprocessable